Welcome to our dedicated page for Medirom Healthcare Technologies news (Ticker: MRM), a resource for investors and traders seeking the latest updates and insights on Medirom Healthcare Technologies stock.
MEDIROM Healthcare Technologies Inc. reports developments across its Japan-based healthcare salon and health-tech businesses. The company operates and franchises wellness salons under the Re.Ra.Ku brand and develops digital preventive healthcare services through products such as Lav, the MOTHER Bracelet smart tracker and the REMONY remote monitoring system.
MRM news commonly covers Re.Ra.Ku salon activity, HealthTech partnerships, distributor agreements for MOTHER Bracelet and REMONY, World ID and Orb authentication initiatives in Japan, subsidiary financing, and treasury or capital-allocation actions involving digital assets. Updates also address American depositary share issuer communications, key performance indicators, and governance announcements tied to the company’s Nasdaq-listed security.
MEDIROM (NASDAQ:MRM) announced a Master Service Agreement with Tools for Humanity effective Feb 2, 2026, and projects approximately USD 39 million income before taxes over the next two years if it expands Orb authentication to ~3,000 locations nationwide.
Orbs are currently installed at >150 locations with cumulative authentications exceeding 20,000, and MEDIROM operates ~300 Re.Ra.Ku wellness salons and other HealthTech businesses.
MEDIROM (NASDAQ: MRM) entered a Master Service Agreement with Tools for Humanity and the World Foundation to support World ID adoption in Japan by installing Orbs at approximately 3,000 locations.
The rollout will expand existing Orb installations (currently >150 at MEDIROM Group wellness centres) to about 300 Re.Ra.Ku salons and to a broader MEDIROM management partner network; MEDIROM is negotiating with 370 third-party locations now. The company described operational, contractual, and regulatory risks and identified forward-looking uncertainties around deployment, verifications, and MSA effectiveness.
MEDIROM (NASDAQ:MRM) reported that cumulative Proof of Human authentications using World ID’s device Orb at Re.Ra.Ku stores surpassed 20,000 verifications as of Dec 28, 2025, doubling from 10,000 on Oct 23, 2025. The company attributes the surge to a 25th anniversary campaign offering free shoulder massages and plans to expand Orb installations to 200 salons nationwide, leveraging Re.Ra.Ku’s network of more than 300 wellness locations to increase public access to Proof of Human technology.
MEDIROM (NASDAQ: MRM) announced on December 29, 2025 a Master Service Agreement with Tools for Humanity and World Foundation to deploy Proof of Human verification across Japan using World ID technology co-created by Sam Altman and Alex Blania.
Under the MSA MEDIROM will operate Proof of Human verification locations leveraging a nationwide network of approximately 300 physical locations, deploy Orbs cameras, establish flagship locations and pop-up stores, and create the MEDIROM World Proof of Human Task Force. The company said operation fees and related services are expected to contribute to revenue over time.
MEDIROM (NASDAQ: MRM) announced a Master Service Agreement with Tools for Humanity and World Foundation to deploy Proof of Human technology (World ID) across Japan, leveraging MEDIROM’s nationwide network of approximately 300 physical locations.
The collaboration covers operation of verification locations, flagship sites, and pop-up stores, and will establish a dedicated MEDIROM World Proof of Human Task Force. MEDIROM said the initiative is expected to contribute to future revenue through operation fees and related services while enabling privacy-preserving human verification at scale.
MEDIROM (NASDAQ: MRM) announced on December 4, 2025 that its subsidiary MOTHER Labs signed a distributor agreement with TD SYNNEX to accelerate nationwide rollout of the recharge-free smart tracker MOTHER Bracelet and the remote monitoring system REMONY.
The partnership will leverage TD SYNNEX's nationwide sales network, global distribution experience and prior track record introducing smart trackers in Japan. MOTHER Bracelet measures five metrics 24/7 without charging, while REMONY pairs the bracelet with a gateway for automatic data sync and real-time centralized monitoring.
MEDIROM MOTHER Labs (NASDAQ: MRM) completed a private placement of new shares to its President and CEO Yoshio Uekusa and Director Ryo Saito on Oct. 30, 2025, as part of a Series A round valued at ¥9 billion.
The company says the management investment aims to enhance decision-making, strengthen business responsibility, and boost growth motivation. The capital increase is intended to strengthen the capital base, accelerate development of upgraded versions of the wearable device “MOTHER Bracelet”, and support systems to launch new products domestically and internationally.
MEDIROM (NASDAQ:MRM) announced a new treasury strategy using cryptocurrency on October 29, 2025. The board resolved to hold Worldcoin (WLD) as a reserve asset and to hold Ethereum (ETH) as a secondary asset, while maintaining cash and deposit liquidity. As of October 28, 2025, the group holds 6,840 WLD. The company plans to distribute WLD as incentives to MOTHER Bracelet users to collect large-scale vital data. MEDIROM said it will perform risk analysis at each board meeting and disclose held-asset status, policies, and risks as necessary.
MEDIROM (NASDAQ: MRM) announced that as of October 23, 2025 it surpassed 10,000 World ID verifications at Re.Ra.Ku and other wellness salons across Japan. The company plans to expand installation of the Orb verification camera to 200 stores. MEDIROM said increased World ID authentications should improve digital proof-of-human convenience and contribute to revenue growth as adoption rises.
MEDIROM MOTHER Labs (NASDAQ: MRM) approved a private placement of new shares to two officers at a Series A valuation of ¥9 billion, with funding scheduled by the end of October 2025. The capital increase is led by management investors Yoshio Uekusa and Ryo Saito to strengthen rapid decision-making and field-rooted management.
The funding will bolster the capital base and support development of an upgraded MOTHER Bracelet wearable and systems for product commercialization, while advancing domestic and international business expansion in healthcare and wellness.